Previous close | 15.50 |
Open | 15.90 |
Bid | 14.80 x N/A |
Ask | 15.10 x N/A |
Day's range | 15.90 - 15.90 |
52-week range | 8.50 - 21.60 |
Volume | |
Avg. volume | 23 |
Market cap | 781.716M |
Beta (5Y monthly) | 1.59 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.11 |
Earnings date | 07 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Cryoport, Inc. (Nasdaq: CYRX), a global leader in supply chain solutions for cell & gene therapies, today announced that the Company will report financial results for the first quarter ended March 31, 2024 on Tuesday, May 7, 2024 after U.S. markets close.
CryoPort (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
There's been a notable change in appetite for Cryoport, Inc. ( NASDAQ:CYRX ) shares in the week since its yearly...